Biomedical, Clinical & Life Sciences

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language 
Only one proposal will be considered by ECA from each applicant organization. In cases where more than one submission from an applicant appears in grants.gov, ECA will only consider the submission made closest in time to the NOFO deadline; that submission would constitute the one and only proposal ECA would review from that applicant.

Executive Summary
The Office of Citizen Exchanges, Global Leaders Division, of the Bureau of Educational and Cultural Affairs (ECA) invites proposal submissions for the FY 2026 TechLeaders: Critical Emerging Technologies Program. TechLeaders will strengthen America’s technological edge and industry dominance by promoting U.S. leadership in Artificial Intelligence (AI), Space Technology, Biotechnology/Health Technology, Supply Chain/Cold Chain Technology, and Agricultural Technology (AgriTech). This initiative engages approximately 60 foreign participants, ages 25-40, from Europe and Eurasia, East Asia and the Pacific, Middle East and North Africa, South and Central Asia, Sub-Saharan Africa, and the Western Hemisphere through a five-week intensive placement in the United States. Participants will collaborate with U.S.- based mentors and companies to develop actionable solutions in critical technology sectors, showcasing American expertise and innovation. The program will also feature overseas components including reciprocal exchanges and an accelerator following the second U.S.-based cohort to expand U.S. influence, inspire future STEM professionals, and foster collaboration with American businesses. TechLeaders supports U.S. national security and foreign policy objectives byexporting American expertise and technological innovations abroad, promoting U.S.- preferred technology standards globally, bolstering economic ties, and countering the proliferation of malign competitors’ technology in the global market.

Organizations applying for this federal award must demonstrate the capacity to recruit, select, and place participants, manage all program logistics, and implement overseas programming, which includes annual reciprocal exchanges and a Critical Emerging Technologies Accelerator program after the second cohort of participants. The recipient will be awarded $ 1,500,000 for the overall FY 2026 TechLeaders: Critical Emerging Technologies Program, ensuring that taxpayer dollars are used efficiently to advance U.S. national interests and global leadership in criticaltechnology sectors.

Limit: 3 // Tickets Available: 0

G. Martin-Alemañy (Nutritional Sciences and Wellness)
B. Tanriover (COM-T)
S. Kharait (COM-T)

Limiting Language
A limit of three proposals from each sponsoring academic institution is imposed to enable fair and broad support for DCI-affiliated investigators.

Overview 
The Paul Teschan Research Fund (PTRF) of Dialysis Clinic, Inc. (DCI) offers grant support for research
related to human kidney disease. Research methods may range from basic science to clinical and
epidemiologic research. Support from this fund, named to honor Paul Teschan, MD, a distinguished
investigator, clinician and advisor to DCI, is intended to promote investigations of current or eventual clinical
significance that might not be able to achieve funding from NIH or other national sources because of their
clinical nature, their early stage of work, or other reasons. The PTRF is a source of funding for worthy
projects where other sources are unavailable.

A limit of three proposals from each sponsoring academic institution is imposed to enable fair and broad
support for DCI-affiliated investigators. Each individual grants are limited to $60,000 per year, including
institutional overhead. The funding period for PTRF research grants is Jan 1 – Dec 31. The initial award
installment is contingent on the project passing DCI’s legal, compliance and regulatory review. This includes
obtaining IRB or IACUC approvals. Subsequent installments are contingent upon adherence to the award
letter.

Preference will be given to earlier research career investigators and to projects considered most relevant
to understanding and treatment of clinical kidney conditions and their complications. All proposals will be
reviewed for scientific merit and significance by external reviewers and also by a panel of DCI-affiliated
nephrologists (Application Review Committee) as part of the competitive application process. Renewal of
ongoing PTRF funding projects is given preference, but is not automatic. Grant awards are merit based.
PTRF grants may not be used to fund salaries of investigators, but may support other personnel active in
the project as approved by DCI. Capital equipment costing $1500 or more may not be included in PTRF
budgets. Overhead is limited to 20% ($10,000). Travel may be requested in the budget during Year 2 and
Year 3 if work from the PTRF project is being presented at a conference, but this may not exceed $1500
per year. No travel will be supported by Year 1 funds. Projects will only be funded for one year at a time
and may be funded for a total of three (3) consecutive years. Year 2 and Year 3 applications will undergo
competitive review by the Application Review Committee for continued funding based on progress
described in a DCI PTRF Study Progress Report. Applications for Year 2 and Year 3 funding will be
reviewed in the same way as an initial application, including reassessment of the scientific merit of the work
proposed as well as the addition of a detailed review of the work accomplished. Grants may not be renewed
in the absence of progress satisfactory reports.

The University of Arizona is not eligible due to an existing award: A current recipient or applicant of the NIOSH T03, Occupational Safety and Health Training Project Grants award is not eligible for an award or a sub-award under this Funding Opportunity Announcement.

Apply to Internal Competition // Limit: 1 // Tickets Available: 1

The University of Arizona Cancer Center (UACC) is coordinating this limited submission. For more information please contact: UACC-PreAward.

Limiting Language
The University of Arizona Cancer Center (UACC) can nominate one applicant.

Purpose of Award:

The UACC is seeking nominations for the V Scholar Grant call which supports adult cancer research. This award supports tenure-track faculty early in their cancer research career by funding projects that are either laboratory-based fundamental research or translational research. The V Scholar Grant supports tenure-track faculty in the early stages of their independent cancer research careers. This grant mechanism is designed to advance exceptional early-career investigators at the Assistant Professor level and position them to successfully compete for larger, sustaining grants such as NIH R01 awards or equivalent funding.

Research on ANY adult cancer type will be funded in this call. Research areas not included in this scope are epidemiology, behavioral science, and health services research.

Award Amount:

• The total grant award is $800,000 over four years, with annual payments of $200,000. No indirect costs allowed.
• The V Foundation follows NIH Guidelines regarding salary caps. Institutions are welcome to supplement a grant recipient’s salary with institutional funds if desired.  

Applicant Eligibility:

Nominee must meet all of the following criteria by the nomination due date:

• Nominated by their Cancer Center Director or similar high ranking research official.
• Employed at a non-profit research institution (e.g., 501c3, Section 170).
• Either a US Citizen or a permanent legal resident in the US.
• Have completed at least two years postdoctoral (MD or PhD) fellowship training. For MDs, a minimum of one year is acceptable if one year is standard for their specialty
• Clinical scientists must have full institutional support (e.g., dedicated lab space, protected research time, start-up funds).
• Hold a full-time, tenure-track or tenured faculty position (e.g., eligible to apply as PI on an R01 at their institution). Non-promotable adjunct, affiliated, temporary, part-time, or acting faculty positions are not eligible.
• Have been appointed to their first full-time, tenure-track Assistant Professor position within five years of the nomination due date and not yet promoted to Associate Professor.
  • Extensions to the five-year limit may be granted on a case-by-case basis for nominees who have taken parental or other qualifying leave during this period.
  • To request approval before submitting the nomination form, email grants@v.org with the following information from your institution:
    • Appointment start date
    • Length and category of leave (e.g., medical, parental)

Request Ticket // Limit: 3 // Tickets Available: 2

P. Madhivanan (Public Health)

Limiting Language
Applications are limited to three submissions per institution. Institutions may submit up to three applications for each Impact Grant track (research grants and fellowship projects and community projects). Institutions are defined by distinct EIN numbers. 

Executive Summary 
The Prevent Cancer Foundation® is the only U.S.-based nonprofit organization solely dedicated to cancer prevention and early detection. Our mission is empowering people to stay ahead of cancer through prevention and early detection. Our vision is a world where cancer is preventable, detectable and beatable for all.  

To advance the Prevent Cancer Foundation’s bold goal to reduce cancer deaths by 40% by 2035, we aim to support innovative research and vital community projects dedicated to increasing and advancing cancer prevention and early detection.  

The goal of the Prevent Cancer Foundation’s research program is to identify and provide funding for innovative projects with the potential to make substantial contributions to cancer prevention and/or early detection. By funding the most promising research, including fellowship projects led by early-career scientists, we contribute to important advances in cancer prevention and early detection.  

The Foundation funds research grants and fellowships at a broad range of academic institutions and cancer centers across the United States, including both well-established and rising institutions advancing cancer research.  


 

Limit: 1 // Tickets Available: 0 

J. Gaither (Emergency Medicine - COM-T) - competitive renewal

Limiting Language 
Eligible applicants may submit one application only to the FY 2026 funding opportunity. If multiple applications are received from the same political subdivision of a State and/or applicant, the last application submitted will be reviewed. If an applicant is eligible for both a Planning and Demonstration Grant and an Implementation Grant, the applicant must choose between applying for a Planning and Demonstration Grant or an Implementation Grant.  

Executive Summary
Funds for the fiscal year (FY) 2026 SS4A grant program are to be awarded on a competitive basis to support planning, infrastructure, and behavioral and operational initiatives to prevent fatalities and serious injuries on roads and streets involving all roadway users, including pedestrians, bicyclists, public transportation, motorists, and commercial vehicle operators.

 

Notify Limited Submissions if you plan to submit a full proposal, include the topic area and lab you plan to submit on behalf of (you must have submitted a solution summary) // Limit: One full proposal (TA1 or TA2) per lab. 

Limiting Language 
Participation in multiple proposals – Only a small fraction of solution summaries are expected to be encouraged for full proposal submissions. At the solution summary stage, proposing entities may submit separate solution summaries for TA1 and TA2 as the prime. However, at the full proposal stage, proposing entities may only submit one full proposal (either TA1 or TA2) as the prime. Proposing entities may be part of multiple full proposal submissions as subcontractors. In this context a ‘proposing entity’ is an academic lab, small business, or unit of a large business. Different labs with different PIs from the same academic institution are considered separate proposing entities.

Introduction
A growing body of evidence suggests that micro- and nano-plastics (MNPs) harm human health. The Systematic Targeting Of MicroPlastics (STOMP) program seeks to better quantify MNPs in humans; understand the mechanisms of MNP deposition; and, ultimately, improve human health by developing means to limit uptake and remove MNPs from the body.

Apply to the Internal Competition // Limit: 3 // Tickets Available: 3

The University of Arizona may submit a total of three nominations:

• One from the College of Medicine - Tucson // Tickets Available: 1
• One from the College of Medicine - Phoenix // Tickets Available: 1
• One from the College of Nursing // Tickets Available: 1

Eligibility:

1. Be a benefits-eligible faculty member in a United States accredited nursing school, allopathic medical school, or osteopathic medical school. Candidates should have approximately three to eight years of faculty experience at the time of application.
2. Be a doctorally prepared faculty member in good standing at the sponsoring school.
3. Be nominated by the dean of the nursing or medical school. There can be only one nominee per nursing or medical school, and a nursing or medical school with a first-year Macy Faculty Scholar is precluded from nominating a candidate.
4. Have an educational scholarship project with the appropriate institutional support.
5. Have a faculty mentor who will advise the candidate on the candidate's educational project and career development.
6. Have an institutional commitment for the protection of 50% of the candidate’s time.
7. Be a citizen or permanent resident of the United States or its territories.

Program Overview

The Macy Faculty Scholars Program, now in its second decade, aims to identify and nurture promising early-career educators in medicine and nursing. The program will help develop the next generation of national leaders in medical and nursing education by identifying outstanding educators, physicians, nurses, and role models—individuals who represent the breadth of diversity seen in learners, patient populations, and health care settings around the country. By providing the Scholars with resources—especially protected time, mentorship, and a professional network of colleagues—the program aims to accelerate Scholars’ careers, to turn their teaching practice into scholarship, and to help them become impactful leaders locally, nationally, and beyond.

This is a career development award. The Foundation is interested in candidates for whom the program will have the maximum impact at this point in their career and who also have the greatest possibility for future impact at their home institutions and beyond. Macy Faculty Scholars will participate in the Macy Faculty Scholars Annual Meeting and will be part of the family of Macy Faculty Scholars for the remainder of their careers.

In order to develop the careers of educators who are future leaders, the Macy Faculty Scholars Program will provide salary support for each Scholar up to $100,000 per year, which will protect 50% of the Scholar’s time over two years. The Scholar will devote this time to a mentored educational scholarly project and other appropriate career development activities.

Apply to Internal Competition // Limit: 3 // Tickets Available: 3

Limiting Language 
The Mathers Foundation Grants Program is a limited competition, where eligible organizations may submit up to three (3) institute-nominated Letter of Inquiry (LOI) applications per grant cycle. 

Program Overview
Full sponsor guidelines are linked here.

The mission of The G. Harold and Leila Y. Mathers Foundation is to advance knowledge in the life sciences by sponsoring scientific research that will benefit mankind. The foundation’s grants program seeks to support basic science, ideally with potential translational applications. Immunology, microbiome, genomics, structural biology, cellular physiology, neuroscience, etc., are some noteworthy examples of current research support.

For many years the Foundation has enjoyed special recognition in the research community for supporting “basic” scientific research, realizing that true transformative breakthroughs usually occur after a thorough understanding of the fundamental mechanisms underlying natural phenomena. More recently, and with the advent of newer investigative methodologies, technology, and tools, the Foundation now embraces innovative translational research proposals.

The grant duration must be three years. The budget should be reasonable based on the aims of the project. Indirect costs may not exceed 10%. Preliminary Budgets are required during the LOI phase. A detailed budget justification is not required until the proposal phase. The Foundation’s grant award is not intended to be utilized for purchasing capital equipment (“bricks-and-mortar”) for the lab and is intended only to support the actual investigation. The Foundation assumes and expects that capital equipment must be provided by the research institution or university.

Application Guidance:

• Grant budgets cannot exceed $600-750K
• The Foundation primarily supports basic science, ideally with potential translational applications.
• Immunology, microbiome, genomics, structural biology, cellular physiology, neuroscience, etc., are some noteworthy examples of current research support.
• Covid-19-related research projects (aims or sub-aims) will not be considered for support.
• Medical imaging technology-related projects and/or electrical engineering technology development projects will not be considered for support.
• Plant Biology Research, Oceanography, Space Exploration. and Global warming-related research will not be considered for support.
• As technology continues to advance, it is apparent that investigations in the area of basic science and translational research may become more and more reliant on collaborative, interdisciplinary projects. It is important to note that any interdisciplinary project proposals may require additional information regarding the collaborator(s)’ achievements and relevant expertise.
• Feedback for declined LOI Requests will not be provided; LOIs or Formal Proposals that have been declined should not be resubmitted at a later date for consideration.
• Renewal applications for the same or related research will not be accorded priority consideration. It is strongly advised that any re-application for grant renewal consider a new direction based on prior research or emphasize some new potential translational aspects and not merely an extension of previously funded research.
• Requests for funding previously federally supported research and/or applications pending federal approval will not be accorded priority consideration.
• Requests for support of clinical trials or drug discovery will not be approved. The Foundation will not support projects which we consider pre-clinical drug development.

The sponsor confirmed that multiple nominations from the same institution are allowed, so applicants are not required to go through the limited submissions process. Interested applicants are encouraged to contact Sara Mathis at the University of Arizona Foundation.